Tannishtha Reya, Ph.D. Tannishtha Reya, Ph.D. Adjunct Professor. Tumor Initiation and Maintenance Program. NCI-Designated Cancer Center. Research; Bio; Tannishtha Reya's Bio. Sanford Burnham Prebys Newsletter. Subscribe to our monthly email newsletter Discoveries. Connect with us.
Dr. Reya received her BA from Williams College and her PhD from the University of Pennsylvania. Subsequently she completed her postdoctoral training at the University of California, San Francisco and Stanford University. Dr. Reya joined the Duke University faculty in 2001 and served as the Co-Director of the Stem Cell Biology and Regenerative Medicine Program at the Duke University.JCCC Seminar. Imaging Stem Cell Signals in Cancer Progression and Therapy Resistance. Tannishtha Reya, PhD. Professor, Pharmacology and Medicine, University of California, San Diego.Tannishtha Reya, PhD University of California San Diego: Randall Hyer, MD, PhD. Joann Sweasy, PhD Joann Sweasy, PhD is an expert in genetics, cell biology, mutagenesis and biochemistry of DNA repair and cancer. She has been funded continuously by the NIH since 1994.
An In Vivo Genome-Wide CRISPR Screen Identifies Novel Dependencies for Blast Crisis Chronic Myelogenous Leukemia Jeevisha Bajaj,. Tannishtha Reya, PhD 4 University of California, San Diego,. and blast crisis Chronic Myelogenous Leukemia.
This is Tannishtha Reya, PhD. For Reporters. EurekAlert! provides eligible reporters with free access to embargoed and breaking news releases.
Tannishtha Reya is a Professor in the Departments of Pharmacology and Medicine and Co-Director of Cancer Biology in the Biomedical Sciences Graduate Program at the University of California San Diego. Her work has provided insight into the signals that control stem cell growth, and how the same signals are subverted to fuel cancer growth.
Students who choose to do their thesis research in laboratories of faculty in the Molecular Pharmacology Training Area of the UC San Diego Biomedical Sciences (BMS) Graduate Program are eligible to be part of the Pharmacological Sciences Training Program (PSTP). The program provides trainees with contemporary education in Pharmacology and state-of-the-art research training in Pharmacological.
This is an extremely powerful tool that allowed us to identify a multitude of genes that fuel leukemia growth and find new vulnerabilities that can be targeted in this disease,” said senior author Tannishtha Reya, PhD, professor in the departments of Pharmacology and Medicine.
The study successfully conducted screenings with genome-wide CRISPR technology by using primary cancer cells in the setting of the native microenvironment, said senior author Tannishtha Reya, PhD, professor in the departments of Pharmacology and Medicine, in a press release. 2.
In an effort to advance research on one of the deadliest forms of cancer, University of California, San Diego School of Medicine researchers Andrew Lowy, MD, and Tannishtha Reya, PhD, have been recruited for their expertise in preclinical modeling, clinical trials and stem cell biology to join a “dream team” of international pancreatic cancer researchers.
Using genome-wide CRISPR technology to identify leukemia's weakness.. Tannishtha Reya, PhD,. Reya and colleagues identified RNA-binding proteins.
Dr. Duncan graduated from the University of North Carolina at Chapel Hill with a BS in Biology in 1996. He attended graduate school at Duke University where he earned a PhD in 2005. Dr. Duncan's graduate work focused on hematopoietic stem cell biology in Dr. Tannishtha Reya's Laboratory in the Department of Pharmacology and Cancer Biology.
Finding Leukemia’s Weakness Using Genome-Wide CRISPR Technology.. that fuel leukemia growth and find new vulnerabilities that can be targeted in this disease,” said senior author Tannishtha Reya, PhD, professor in the departments of Pharmacology and Medicine.. Reya and colleagues identified RNA-binding proteins — which normally.
Finding Leukemia’s Weakness Using Genome-Wide CRISPR Technology 8:50 April 20, 2020 A team of researchers at University of California San Diego School of Medicine and Moores Cancer Center used CRISPR technology to identify key regulators of aggressive chronic myeloid leukemia, a type of cancer that remains difficult to treat and is marked by frequent relapse.
Targeting Stem Cell Signals in Pancreatic Cancer: Team leader: Tannishtha Reya, PhD, University of California San Diego School of Medicine; co-leaders: Andrew M. Lowy, MD, UC San Diego Moores Cancer Center, and Margaret A. Tempero, MD, University of California San Francisco.
Tannishtha Reya, PhD was awarded a 2017 UC Drug Discovery Consortium seed grant. This cross-campus initiative, funded by the Office of the President through an MRPI award, aims to advance drug discovery capabilities and success at the University of California.
Experiments carried out by Tannishtha Reya, PhD, a former postdoctoral fellow in Weissman’s lab, found that after a week in an environment containing Wnt, mouse hematopoietic stem cells were about six times more likely to be dividing than cells grown in control conditions.